Since changes in the immune TME of GPR55 KO mice were more pronounced in KPCY55 than KPCY tumors, and high expression of GPR55 was reported in human pancreatic cancer (28), we used KPCY55 tumors for RNA-seq evaluation and for further in vivo experiments. The gene discussed is GPR55; the disease is pancreatic neoplasm.